Indusatumab vedotin

From WikiMD's Wellness Encyclopedia

Indusatumab vedotin is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Seattle Genetics.

Mechanism of Action[edit | edit source]

Indusatumab vedotin is an antibody-drug conjugate (ADC) that combines an antibody specific for tissue factor (TF), a protein that plays a role in tumor growth and progression, with a potent cell-killing agent. The antibody portion of the ADC binds to TF on the surface of cancer cells, delivering the cell-killing agent directly to the cells.

Clinical Trials[edit | edit source]

Indusatumab vedotin has been evaluated in several clinical trials for the treatment of various types of cancer. These trials have shown promising results, with some patients experiencing significant reductions in tumor size.

Side Effects[edit | edit source]

Like all drugs, indusatumab vedotin can cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, and decreased appetite. More serious side effects can include nerve damage and low blood cell counts.

See Also[edit | edit source]

References[edit | edit source]


Indusatumab vedotin Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD